About this trial
This study is about understanding how a condition called pachychoroid changes over time. Pachychoroid refers to an anatomic choroidal characteristic with abnormally thick choroid or abnormally dilated Haller's vessels. Pachychoroid can range from mild forms which does not cause any problems to more serious ones that might cause vision loss.This study will recruit participants with pachychoroid, to learn more about how this condition develops, how it affects people in the long run, and what factors might make it worse.
Eligibility criteria
Qualifiers
Adults aged 45 years or older.
Presence of pachyvessels on ultra-widefield (UWF) imaging in at least one quadrant.
Willing to undergo pupil dilation, and protocol-required procedures for both eyes
Willing to provide written informed consent
Disqualifiers
Presence of disorders of the ocular media which interfere with visual acuity and other ocular assessments during the study period
Eyes with other ocular pathology such as trauma, inflammation, previous intraocular surgery (except for cataract surgery)
Systemic diseases that might affect ocular blood flow such as uncontrolled hypertension, autoimmune disease, and haematological disorders
Pregnant or nursing women
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Singapore National Eye Centre
Lead sponsor
National University Hospital, Singapore
Collaborator
University of Malaya
Collaborator
Hong Kong University
Collaborator